<SEC-DOCUMENT>0001437749-19-009854.txt : 20190514
<SEC-HEADER>0001437749-19-009854.hdr.sgml : 20190514
<ACCEPTANCE-DATETIME>20190514165109
ACCESSION NUMBER:		0001437749-19-009854
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190514
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190514
DATE AS OF CHANGE:		20190514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GeoVax Labs, Inc.
		CENTRAL INDEX KEY:			0000832489
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				870455038
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52091
		FILM NUMBER:		19823506

	BUSINESS ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			2Q
		ZIP:			30080
		BUSINESS PHONE:		678-384-7220

	MAIL ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			2Q
		ZIP:			30080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Geovax Labs, Inc.
		DATE OF NAME CHANGE:	20061002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAUPHIN TECHNOLOGY INC
		DATE OF NAME CHANGE:	19940826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUCCESSO INC
		DATE OF NAME CHANGE:	19910410
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>govx20190513_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>
<head>
	<title>govx20190513_8k.htm</title>

	<!-- Created by RDG HTML Converter v1.1.0.0 5/13/2019 2:24:00 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no"/>
</head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:18pt;margin:0pt;text-align:center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto">
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:18pt;margin:0pt;text-align:center;"><b>FORM 8-K</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>CURRENT REPORT</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Pursuant to Section 13 or 15(d) of the</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Securities Exchange Act of 1934</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Date of report (Date of earliest event reported):&nbsp;&nbsp;</b><b>May<b> </b>14, 2019</b></p>

<p style="margin: 0pt;">&nbsp;</p>

<p style="margin: 0pt;">&nbsp;</p>

<p style="margin: 0pt;">&nbsp;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto">
<p style="font-family:'Times New Roman', Times, serif;font-size:18pt;margin:0pt;text-align:center;"><b>GEOVAX LABS, INC.</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(Exact name of registrant as specified in its charter)</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:32%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Delaware</b></p>
			</td>
			<td style="vertical-align:bottom;width:2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:32%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>000-52091</b></p>
			</td>
			<td style="vertical-align:bottom;width:2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:32%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>87-0455038</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:32%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(State or other jurisdiction of</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>incorporation or organization)</b></p>
			</td>
			<td style="vertical-align:bottom;width:2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:32%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(Commission File No.)</b></p>
			</td>
			<td style="vertical-align:bottom;width:2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:32%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(IRS Employee Identification No.)</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>1900 Lake Park Drive, Suite 380</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Smyrna, Georgia 30080</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(Address of principal executive offices) (Zip code)</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(678) 384-7220</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(Registrant&rsquo;s telephone number, including area code)</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="vertical-align: top; border-width: thin thin 1px; border-style: solid; border-color: rgb(0, 0, 0); width: 35%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Title of each class</p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 30%; border-top: thin solid rgb(0, 0, 0); border-right: thin solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Trading Symbol(s)</p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 35%; border-right: thin solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Name of each exchange on which registered</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 35%; border-right: thin solid rgb(0, 0, 0); border-left: thin solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">Common Stock, $0.001 par value</p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 30%; border-right: thin solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">GOVX</p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 35%; border-right: thin solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">OTCQB</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">[&nbsp;&nbsp;] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">[&nbsp;&nbsp;] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR240.14a-12)</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">[&nbsp;&nbsp;] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">[&nbsp;&nbsp;] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13(e)-4(c))</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Emerging growth company [&nbsp; ]</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial reporting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act. [&nbsp; ]</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">This Form 8-K and other reports filed by GeoVax Labs, Inc. (the &ldquo;Company&rdquo;) from time to time with the Securities and Exchange Commission (collectively the &ldquo;Filings&rdquo;) contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company&rsquo;s management as well as estimates and assumptions made by the Company&rsquo;s management.&nbsp;&nbsp;When used in the Filings, the words &ldquo;anticipate&rdquo;, &ldquo;believe&rdquo;, &ldquo;estimate&rdquo;, &ldquo;expect&rdquo;, &ldquo;future&rdquo;, &ldquo;intend&rdquo;, &ldquo;plan&rdquo; or the negative of these terms and similar expressions as they relate to the Company or the Company&rsquo;s management identify forward-looking statements.&nbsp;&nbsp;Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to the Company&rsquo;s industry, operations and results of operations and any businesses that may be acquired by the Company.&nbsp;&nbsp;Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.&nbsp;&nbsp;Except as required by law, the Company does not undertake to update its forward-looking statements.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Item 2.02&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">On May 14, 2019 we issued a press release reporting our results of operations for the quarter ended March 31, 2019. A copy of the press release is attached to this Current Report.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><a href="ex_144743.htm" style="-sec-extract:exhibit;">Exhibit 99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press Release</a></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>SIGNATURE</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Dated: May 14, 2019</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:50%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:top;width:38%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">GEOVAX LABS, INC.</p>
			</td>
			<td style="vertical-align:top;width:12%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:50%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:top;width:38%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:12%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:50%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:top;width:38%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:12%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:50%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:3.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">By:</p>
			</td>
			<td style="vertical-align:top;border-bottom:solid 1px #000000;;width:35%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">/s/ Mark W. Reynolds</p>
			</td>
			<td style="vertical-align:top;width:12%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:50%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:3.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:35%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Mark W. Reynolds</p>
			</td>
			<td style="vertical-align:top;width:12%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:50%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:3.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:35%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Chief Financial Officer</p>
			</td>
			<td style="vertical-align:top;width:12%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2</p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_144743.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
<head>
	<title>ex_144743.htm</title>

	<!-- Created by RDG HTML Converter v1.1.0.0 5/13/2019 2:18:33 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no"/>
</head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0in 0.1in; cursor: auto;">
<p style="margin-bottom: 0px; text-align: right; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin-bottom: 0px; text-align: left; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font><img src="logo01.jpg"></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;"><b>GeoVax </b><b>Reports</b><b> </b><b>201</b><b>9</b><b> First</b><b> </b><b>Quarter</b><b> </b><b>Financial Results</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;"><b>and </b><b>Highlights </b><b>Corporate Development </b><b>Progress</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>ATLANTA, G</b><b>A</b><b>, </b><b>May</b><b> </b><b>1</b><b>4</b><b>, 201</b><b>9</b><b> </b>&ndash; GeoVax Labs, Inc. (OTCQB: GOVXD), a biotechnology company developing human vaccines, today announced its financial results for the three months ended March 31, 2019 and provided an update on its corporate development progress.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">David A. Dodd, GeoVax&rsquo;s President and CEO, commented, &ldquo;To date during 2019, we continue to make progress in several of our key focus areas despite the limited capital resources which have constrained our activities. Nonetheless, through the efforts of our dedicated staff here are a few recent examples of our collaboration and funding achievements:</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:18pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>-</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>Cancer Immunotherapy</b> &ndash; We continued our work with Leidos, Inc. under our collaboration to evaluate delivery of Leidos&rsquo; novel PD-1 checkpoint inhibitors with our MVA-VLP platform for multiple immunotherapeutic vaccine candidates;</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:18pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>-</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>Malaria </b><b>V</b><b>accine </b>&ndash; We expanded our relationship with Leidos to include development of malaria vaccine candidates supported under a contract to Leidos from the United States Agency for International Development (USAID) Malaria Vaccine Development Program (MVDP);</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:18pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>-</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>Lassa Fever </b><b>V</b><b>accine</b> &ndash; We continued our progress in this program with support from a U.S. Department of Defense grant to advance the vaccine through nonhuman primate testing and manufacturing process development in preparation for human clinical trials;</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:18pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>-</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>Zika, Lassa, Ebola and Marburg </b><b>V</b><b>accines, </b><b>U</b><b>nique </b><b>D</b><b>elivery</b> &ndash; We began a collaboration with Enesi Pharma related to their novel, needle-free ImplaVax&reg; device. We expect this program to result in development of thermostable solid-dose needle-free vaccines for a variety of infectious diseases;</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:18pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>-</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>HIV</b><b> Preventive</b><b> </b><b>V</b><b>accine</b> &ndash; We are progressing to the next stage of human clinical testing with support from the HIV Vaccine Trials Network (HVTN) and funding from the National Institute of Allergy and Infectious Diseases (NIAID). We expect HVTN to begin the next study (HVTN 132) within the next several months;</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:18pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>-</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>HIV &ldquo;Cure&rdquo; Program</b>; Our collaboration with American Gene Technologies International, Inc. (AGT), for use of our vaccine in combination with AGT&rsquo;s gene therapy for development of a functional cure for HIV, is on track to enter human clinical trials sponsored by AGT during the second half of 2019. We also are continuing discussions with other consortiums for the use of our vaccine in similar efforts toward developing a cure for HIV infection;</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:18pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>-</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>Joint Development Collaborations </b>&ndash; We continue to engage in promising discussions related to various joint development collaborations that may result in full product development agreements, as well as strategic investments by potential partners.</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Mr. Dodd continued, &ldquo;We are intent upon entering clinical development status for one or more of our development programs within the next 12-18 months, expanding beyond and building upon, our HIV clinical trials. To that end, our goals include restructuring our equity capital, including new capital investment, with our shares trading on a more acceptable stock exchange (e.g. Nasdaq) that will support and sustain the level of operational investment necessary to proceed into human clinical trials. On May 2, 2019, we took one step toward realizing this goal by effecting a one-for-five hundred (1:500) reverse split of our common stock, following shareholder approval of the reverse split on April 15. While this may be an unpopular action among some of our shareholders, it is necessary to ensure our access to the capital critical to continue with and, more importantly, to accelerate our promising product development. There is still additional work needed to be done before we can realistically achieve a Nasdaq listing and a larger capital raise, but that remains our goal and we are confident we will be successful &ndash; the promise of our science is too good for us to fail.&rdquo;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Financial Review</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">GeoVax reported a net loss for the three months ended March 31, 2019 of $701,454, or $1.43 per share, based on 491,707 weighted-average shares outstanding. For the three months ended March 31, 2018, the Company reported a loss of $621,813, or $2.50 per share, based on 248,340 weighted-average shares outstanding. The Company reported revenues of $364,232 for the three months ended March 31, 2019, primarily related to grants from the NIH. This compares to $221,299 of grant revenues reported for the same period in 2018. Research and development (R&amp;D) expenses were $555,718 for the three months ended March 31, 2019, compared with $486,994 for the comparable period in 2018. General and administrative (G&amp;A) expenses were $510,064 and $357,228 for the three months ended March 31, 2019 and 2018, respectively. Cash balances were $175,985 at March 31, 2019, as compared to $259,701 at December 31, 2018.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%">MORE</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Summarized financial information is attached. Further information concerning the Company&rsquo;s financial position and results of operations are included in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>About GeoVax</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. On this platform, MVA, a large virus capable of carrying several vaccine antigens, expresses proteins that assemble into VLP immunogens within (<i>in vivo</i>) the person receiving the vaccine. The production of VLPs in the person being vaccinated mimics virus production in a natural infection, stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. The MVA-VLP derived vaccines elicit durable immune responses in the host similar to a live-attenuated virus, while providing the safety characteristics of a replication-defective vector.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">GeoVax&rsquo;s current development programs are focused on preventive vaccines against HIV, Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa), and malaria, as well as therapeutic vaccines against chronic Hepatitis B infections and cancers. The Company has designed the leading preventative HIV vaccine candidate to fight against the subtype of HIV prevalent in the larger commercial markets of the Americas, Western Europe, Japan, and Australia; this program is currently undergoing human clinical trials managed by the HIV Vaccine Trials Network (HVTN) with the support of the National Institutes of Health (NIH). GeoVax&rsquo;s HIV vaccine is also part of collaborative efforts to develop an immunotherapy as a functional cure for HIV. For more information, visit <u>www.geovax.com</u>.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b>Forward-Looking Statements</b></i></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Certain statements in this document are &quot;forward-looking statements&quot; within the meaning of the Private Securities Litigation Reform Act. These statements are based on management&#39;s current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax can develop and manufacture its vaccines with the desired characteristics in a timely manner, GeoVax&#39;s vaccines will be safe for human use, GeoVax&#39;s vaccines will effectively prevent targeted infections in humans, GeoVax&rsquo;s vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective or easier to use than GeoVax&#39;s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking </i><i>statements and</i><i> does not intend to do so. More information about these factors is contained in GeoVax&#39;s filings with the </i><i>SEC</i><i> including those set forth at &quot;Risk Factors&quot; in GeoVax&#39;s Form 10-K</i><i>.</i></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Contact: </b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">GeoVax Labs, Inc.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">investor@geovax.com</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">678-384-7220</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>FINANCIAL TABLES FOLLOW</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%">MORE</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td colspan="8" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>GEOVAX LABS, INC.</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="8" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Condensed Consolidated Statements of Operations Information</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="8" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><i>(amounts in thousands, except </i><i>share and </i><i>per share data)</i></p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="6" id=".amt.D4" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Three Months Ended</p>
			</td>
			<td id=".trail.D4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td colspan="6" id=".amt.D4" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">March 31,</p>
			</td>
			<td id=".trail.D4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="2" id=".amt.D4" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</p>
			</td>
			<td id=".trail.D4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Grant and collaboration revenues</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">364</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">221</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Operating expenses:</p>
			</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B4" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 66.4%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Research and development</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">556</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">487</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">General and administrative</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">510</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">357</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,066</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">844</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Loss from operations</p>
			</td>
			<td id=".lead.3" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(702</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.4" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(623</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Other income (expense), net</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Net loss</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(701</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(622</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Net loss per common share</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(1.43</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(2.50</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Weighted average common shares outstanding</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">491,707</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">248,340</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td colspan="8" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>&nbsp;Condensed </b><b>Consolidated </b><b>Balance Sheet Information</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="8" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><i>(amounts in thousands)</i></p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">March 31,</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Dec. 31,</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Assets:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Cash and cash equivalents</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">176</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">260</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Other current assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">272</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">360</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Total current assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">448</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">620</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt;">Property, net</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">11</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt;">Other assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">11</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">11</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt;">Total assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">473</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">642</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Liabilities and stockholders&rsquo; equity (deficiency)</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Current liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,645</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,624</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Note payable, net of current portion</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">35</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">40</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Stockholders&rsquo; equity (deficiency)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,207</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,022</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Total liabilities and stockholders&rsquo; equity (deficiency)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">473</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">642</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Common Shares Outstanding</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">556,489</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">437,807</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">###</p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo01.jpg
<TEXT>
begin 644 logo01.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_[@ A061O8F4 9$     ! P 0 P(#!@
M             /_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$! 0$!
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\( $0@ -0#' P$1  (1 0,1 ?_$ /$   (# 0$  P$!
M      D*  <(!@4"! L! P$  @,! 0$!            !08 ! <# @@!$
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MZS]-M_(7XKEZL]?BO[W]K/-YB7RS^&C]?>[I7R3Z(_K>N%[][5X%O-TU_]H
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MJ[HQ;O1QM3Y,<K",,;(BZ(NB-D;K)S>1\2PB)P\S#-T3VHF8^5 <6/F+?O\
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MUX_Z7_\ GGQE7_++])>4]S7_ '8]MO=GTAYOVSKT_P";^L?Z5]3^7]3DZ/\
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KG",F8B1; T33N59,C$)P3<YI"1B'=;34(E(A(M8EM3E7IW+%>12;IK?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
